Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report

7Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Rationale:Malignant phyllodes tumors of the breast are rare, and there are currently no guidelines and a large number of clinical trials to guide the treatment of recurrence tumor. Here we reported a case of radiotherapy with apatinib for the treatment of recurrent malignant phyllodes tumor of the breast.Patient concerns:A 58-year-old patient with massive breast mass was admitted to our hospital. Two months after surgical treatment, the tumor recurred in the chest wall scar.Diagnoses:The histopathologic diagnoses was right breast malignant phyllodes tumor with chondrosarcomas and osteosarcomas in some areas.Interventions:The patient was first treated with surgery. Malignant phyllodes tumor recurred in the chest wall two months after surgery and was treated with radiotherapy and apatinib.Outcomes:With surgery, radiotherapy and apatinib treatment, the patient still died within several months.Lessons:Apatinib and radiotherapy failed to obtain good therapeutic effect in the recurrence of breast malignant phyllodes tumor in this case.

Cite

CITATION STYLE

APA

Wu, H., Li, L., Yang, J., Guo, C., Zhang, W., & Wang, H. (2020). Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report. Medicine (United States), 99(3). https://doi.org/10.1097/MD.0000000000018808

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free